Supplement safety · public sources

Vitamin D safety

FDA adverse-event reports, NIH guidance on interactions, and registered trials.

What public sources say about the safety of vitamin D: FDA adverse-event reports, NIH guidance on interactions with medicines, and the registered trials that test it.

⚠️
Research information, not medical advice. Supplements can interact with prescription medicines and affect conditions. Check with a pharmacist or your own clinician before starting or stopping one. Nothing here is a dose recommendation.

Interactions and safety, in NIH's words

Vitamin D supplements may interact with medications, and some medications may affect vitamin D levels. These medications include orlistat, statins, steroids, and thiazide diuretics.

Vitamin D supplements may interact with several types of medications. A few examples are provided below. Individuals taking these and other medications on a regular basis should discuss their vitamin D intakes and status with their health care providers.

The weight-loss drug orlistat (Xenical and alli), together with a reduced-fat diet, can reduce the absorption of vitamin D from food and supplements, leading to lower 25(OH)D levels [167-170].

Medicines covered in that section: Orlistat, Statins, Steroids, Thiazide diuretics.

Quoted from the “Interactions with Medications” section: NIH Office of Dietary Supplements, health-professional fact sheet, retrieved 2026-11-16. Read the full page for the complete list and references.

FDA adverse-event reports (CAERS)

Reports are not rates. CAERS counts voluntary reports to the FDA from consumers, clinicians and companies. A report means someone linked a health problem to a product, not that the product caused it. There is no denominator: how many people took the product is unknown, so these numbers cannot show how common a problem is, and they cannot be compared between products. Popular products attract more reports.
981reports naming it in a suspect product
184where the product is named for it alone
2008–2026years covered, single-ingredient reports

Matching rule: reports in the dietary-supplement category where a product marked "suspect" has a brand name containing “VITAMIN D”. Products that contain it without naming it are missed. Reports where it was only taken alongside the suspect product are not counted.

Combination products: 797 of the reports involve only products whose name lists another ingredient, such as calcium or a multivitamin. Their reactions may come from that other ingredient or from the tablet itself, so the reactions below count only the 184 reports where a product is named for vitamin D alone. This split is made from product names and can misfile some products. Most-reported products: Caltrate 600 + Vitamin D (157); Vitamin D (50); Caltrate 600 +Vitamin D (27); Citracal Calcium + D Slow Release 1200 (26); Caltrate 600 + D Plus Mineral (22); Caltrate 600 Plus Chewable (21).

Most reported reactions, single-ingredient reports
Most reported reactions (single-ingredient products)Reports
Diarrhoea16
Dyspnoea15
Vomiting14
Headache10
Hypersensitivity10
Blood calcium increased9
Dizziness9
Nausea9
Malaise8
Muscle spasms8
Choking8
Dehydration7

Outcomes recorded in these reports (a report can have several): Other Serious or Important Medical Event (108), Hospitalization (63), Visited a Health Care Provider (40), Visited Emergency Room (35), Other Serious Outcome (27), Life Threatening (18), Disability (13), Other Outcome (8).

Source: openFDA food and supplement adverse events (CAERS), retrieved 2026-11-16.

Registered trials

392 trials in the non-drug evidence map test this class of supplement. Trials with posted results are listed first; each shows the condition it was registered for. A trial testing it in one condition says nothing about another.

All supplement safety pages Non-drug evidence map